Portfolio

Filter on

Investment Portfolio

18 companies
Biotech
Ongoing
Bonevet
Sector: Biotech
Employees: 5

Vet biopharma developing products for the treatment of orthopedic (bone, joint, tendon/ligament) conditions in dogs and horses.

Biotech
Ongoing
Chromacure
Sector: Biotech
Employees:

ChromaCure’s mission is to discover and develop first-in-class small molecule therapeutics for unmet needs in oncology.

Biotech
Ongoing
EPICS Therapeutics
Sector: Biotech
Employees:

EPICS Therapeutics is a newly created company dedicated to develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics

Biotech
Exit
Ogeda logo
Sector: Biotech
Employees: 41

Clinical-stage drug discovery company that invents and develops small molecule drugs. It has been acquired by Astellas in 2017 for 800 M€ (publicly disclosed).

Biotech
Exit
Masthercell logo
Sector: Biotech
Employees: 73

Dynamic and global Contract Development and Manufacturing Organization for cell therapy companies. It has entered a share deal with Orgenesis in 2015.

Fintech
Ongoing
Virteo
Sector: Fintech
Employees: 14

A single platform for all your debt collection partners
Benchmark them, reduce costs and improve your net recovery rate

ULB logo

ULB & THEODORUS

A 15 year-old partnership

How we build upon the ULB expertise

We are Theodorus,

THE ULB SPIN-OFF FUND
AND WE ARE LOOKING FORWARD
TO MEETING YOU!